Optimized formulation for topical application of a fixed combination halobetasol/tazarotene lotion using polymeric emulsion technology.

Conclusions: Fixed combination HP 0.01%/TAZ 0.045% lotion formulation utilizing innovative polymeric emulsion technology and optimal selection of solvents/emollients/humectants, has recently been developed. Features inherent in the technology translate into rapid, sustained efficacy, low irritation and good patient acceptance. PMID: 31522563 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31522563?dopt=Abstract

Source: Journal of Dermatological Treatment - September 18, 2019 Category: Dermatology Tags: J Dermatolog Treat Source Type: research

More News: Dermatology | Psoriasis | Skin | Study